Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of flavonoid compound prodrug and use thereof

A compound and prodrug technology, applied in the field of prodrugs of flavonoids, can solve the problems of poor solubility and low bioavailability

Active Publication Date: 2017-08-22
BEIJING SHENOGEN PHARMA GRP
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0017] However, although the above-disclosed flavonoids have good pharmaceutical activity, these compounds have a common disadvantage: poor solubility in water, and the bioavailability of the prepared oral preparations is very low after biological administration

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of flavonoid compound prodrug and use thereof
  • A kind of flavonoid compound prodrug and use thereof
  • A kind of flavonoid compound prodrug and use thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0064] Preparation of Alcoradine

[0065] Acradine, also known as icariin, is extracted and separated from the traditional Chinese medicine Epimedium, and its structure is shown in the following formula (G).

[0066]

[0067] The preparation method of icariin is disclosed in the patent whose publication number is CN101302548. In the method, icariin is used as a raw material, hydrolyzed by β-glucosidase, the precipitate obtained by centrifuging the hydrolyzed product is dissolved in acetone, and the supernatant is obtained by centrifuging and filtering. The supernatant obtained by centrifugation is then recrystallized with water to obtain pure icariin, which is in the form of yellow powder crystals. The icariin in the present invention was purchased from Shaanxi Jiahe Plant Chemical Co., Ltd., with a purity of 90%.

Embodiment 2

[0069] 3,5-Dihydroxy-8-(3-methyl-2-butenyl)-2-(4-methoxyphenyl)-7-(4H-chromen-4-one)phosphonic acid di Synthesis and identification of sodium ester (formula I compound), synthetic route is as follows:

[0070]

[0071] Compound H 3,5-dihydroxy-8-(3-methyl-2-butenyl)-2-(4-methoxyphenyl)-7-(4H-benzopyridine Preparation of pyran-4-one) diethyl phosphate

[0072] Compound G 3,5,7-trihydroxy-8-(3-methyl-2-butenyl)-2-(4-methoxyphenyl)-7-(4H-benzopyran-4 -ketone) (7.4g, 20mmol, 1.0eq) was dissolved in 100ml of anhydrous tetrahydrofuran (THF), added DIPEA (15ml, 83.7mmol, 4.2eq), stirred well, added DMAP (0.24g, 2mmol, 10%mol), Cool down to -10°C, slowly add CCl dropwise 4 (3ml, 31mmol, 1.5eq), 10ml of anhydrous THF solution of diethyl phosphite (3.32g, 2.4mmol, 1.2eq), slowly rise to room temperature for reaction, thin-layer chromatography (silica gel plate loading material, developing agent is acetic acid Ethyl ester and petroleum ether 1:2, 254nm ultraviolet lamp color) m...

Embodiment 3

[0094] 3,5-Dihydroxy-8-(3-methyl-2-butenyl)-2-(4-methoxyphenyl)-7-(4H-chromen-4-one) Synthesis and Identification of Preparation of Sodium Sulfate

[0095]

[0096] Compound G (3.68g, 10mmol, 1.0eq) was dissolved in 40ml of dry pyridine / dimethylformamide (DMF) (1:1 v / v), slowly added in batches to pyridine sulfur trioxide complex (C 5 h 5 NSO 3 ) (4.8g, 30mmol, 6.0eq), after the addition is complete, keep away from light, heat and stir the reaction at 50-60°C, thin-layer chromatography (silica gel plate loading material, developing agent is ethyl acetate and petroleum ether 2:1, 254nm UV Light color) Monitor until compound G disappears completely, the reaction solution naturally cools down to room temperature, cools down to 0°C in an ice bath, slowly adds 30ml of water under stirring and stirs for 30 minutes, adjusts the pH value to 13 with 1mol / l NaOH, evaporates to dryness and removes Pyridine and DMF, add 40ml of water, add dropwise 1mol / l sulfuric acid to acidify ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides a flavonoid compound prodrug, its pharmaceutically acceptable salt or solvate, the prodrug is shown in the following formula (I), the present invention by the hydrogen of the hydroxyl with sulfate or sulfuric acid ester, carbonic acid Salt or carbonate, and phosphate or phosphate substitution, made the prodrugs of the above flavonoids. The prodrug overcomes the defects of poor water solubility and low bioavailability of the original flavonoids

Description

technical field [0001] The invention relates to a prodrug of a flavonoid compound and its application, belonging to the field of medicine. Background technique [0002] Flavonoids are a class of compounds that exist in nature and have a 2-phenylchromone core, as shown in the following formula (A). Because there is a ketone carbonyl group in the molecule of this kind of compound, the first oxygen atom is basic and can form a salt with strong acid, and its hydroxyl derivatives are mostly yellow, so they are called flavones. [0003] [0004] Studies have shown that flavonoids have a variety of biological activities, such as cardiovascular system activity, antibacterial and antiviral activity, antitumor activity, antioxidant free radical activity, anti-inflammatory and analgesic activity, and liver protection activity. [0005] At present, more and more specific flavonoids have entered the drug development process and made progress in research and development. For example,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F9/655C07D311/30C07D405/12A61K31/661A61K31/4545A61K31/496A61K31/352A61P35/00
Inventor 王永钢张建存孟坤
Owner BEIJING SHENOGEN PHARMA GRP